GG 615 GG 615 (Ranitidine 300 mg)

This pill with imprint "GG 615 GG 615" is Brown, Capsule-shape and has been identified as Ranitidine hydrochloride 300 mg. It is manufactured by Sandoz Pharmaceuticals Inc..

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; eczema; zollinger-ellison syndrome (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride

Imprint:

GG 615 GG 615

Strength:

300 mg

Color:

Brown

Size:

19.00 mm

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

H2 antagonists

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Sandoz Pharmaceuticals Inc.

National Drug Code (NDC):

00781-2865

Inactive Ingredients:

ammonia
corn starch
FD&C Blue No. 1
FD&C Red No. 40
FD&C Yellow No. 6
gelatin
magnesium stearate
propylene glycol
silicon dioxide
sodium lauryl sulfate
sodium starch glycolate type A potato
titanium dioxide

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.